Oppenheimer analyst Hartaj Singh downgraded Vertex (NASDAQ: VRTX) from to Perform.The analyst said: "VRTX reported Ph2 results for suzetrigine in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE